Nine-month interim report (Q3) 2026 (unaudited)

Summary by AI BETAClose X

ALK reported Q3 revenue of DKK 1,764m, up 15% (l.c.), driven by tablet sales of DKK 999m (+35%) while SCIT/SLIT sales fell 6% to DKK 527m. Operating profit (EBIT) increased 9% to DKK 469m with an EBIT margin of 27% (28% for the first nine months); Q3 free cash flow was DKK 303m and 9M free cash flow was DKK 1,192m, while net debt/EBITDA stood at negative 0.7. The company confirmed its upgraded FY26 guidance of 16-17% revenue growth (l.c.) and an EBIT margin around 27%, and reported material commercial and regulatory progress including a successful ACARIZAX phase 3 in China (filing H1 2027), neffy launches and expanded tablet supply capacity.

Disclaimer*

UK 100

Latest directors dealings